Parkinson’s disease is one of the most common neurodegenerative conditions worldwide. In Colombia, more than 220,000 people suffer from this disease, according to the Colombian Association of Neurology. As the disease progresses, patients may experience debilitating symptoms such as muscle rigidity, tremors, sleep disorders, anxiety, and psychosis.
In this context, scientific research has shown that cannabidiol (CBD), a non-psychoactive compound from cannabis, could offer neuroprotection and improve the quality of life for patients with Parkinson’s.
CBD as a Neuroprotective Therapy
Studies conducted by the University of Louisville School of Medicine in Kentucky have identified that CBD possesses antioxidant and anti-inflammatory properties that help protect the brain from progressive cellular damage. It has been observed that its use can improve the activity of the basal ganglia in the brain, key structures in movement control, contributing to the reduction of motor symptoms.
Additionally, CBD has shown effectiveness in managing anxiety, psychosis, and sleep disorders associated with Parkinson’s, providing relief to patients and improving their overall well-being.
The Endocannabinoid System and Movement Regulation
The endocannabinoid system (ECS) plays a fundamental role in neuromodulation, regulating processes such as motor control and neuronal inflammation. Recent studies suggest that activating this system with cannabinoids like CBD could slow the progression of motor symptoms and improve neurological functionality in people with Parkinson’s.
Perspective from Tarkus Pharma Lab
Alejandro Venegas, CEO and Founder of Tarkus Pharma Lab, emphasizes the value of CBD in modern medicine:
“Cannabidiol’s rise in the market responds to the growing demand for natural solutions with a high safety profile and scientific backing. Cannabis derivatives not only offer an innovative approach to diseases like Parkinson’s, but also improve patients’ quality of life without causing addiction or adverse side effects.”
A Promising Future for Parkinson’s Treatment
Research on medicinal cannabis and neuroprotection is advancing rapidly, opening new opportunities for the treatment of diseases like Parkinson’s. With each study, CBD reaffirms its therapeutic potential, offering a safe and effective alternative to improve patients’ quality of life.
📢 Follow our updates and discover how Tarkus Pharma Lab is driving the future of medicine with pharmaceutical cannabis.
[/et_pb_text][/et_pb_column] [/et_pb_row] [/et_pb_section]
